# Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

> **NCT00615173** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 81 (actual)

## Conditions studied

- Kidney Diseases
- Lupus Nephritis
- Tacrolimus
- Induction Phase
- Maintenance Phase

## Interventions

- **DRUG:** tacrolimus (FK506)
- **DRUG:** cyclophosphamide or azathioprine

## Key facts

- **NCT ID:** NCT00615173
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2008-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615173, "Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00615173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*